CNS Neuroscience & Therapeutics · 2022 · 44 citations · 34 references
MedicineNeurologyNeuroscienceDementiaNeuro-ophthalmologyNeurodegenerationAlzheimer DiseaseCognitive ImpairmentDementia BiomarkersDementia DiagnosisOptical Coherence TomographyRetinal AnatomyMacular Optical Coherence TomographyMacular Thickness MeasurementOptical Coherence Tomography BiomarkersPeripapillary Retinal Nerve Fiber LayerRetinal Biomarker QuantificationRetinal Layer ThicknessRetinal Nerve Fiber Layer ThinningRetinal Thickness Analysis
Abstract Aims We mainly evaluate retinal alterations in Alzheimer's disease (AD) patients, investigate the associations between retinal changes with AD biomarkers, and explore an optimal machine learning (ML) model for AD diagnosis based on retinal thickness. Methods A total of 159 AD patients and 299 healthy controls were enrolled. The retinal parameters of each participant were measured using optical coherence tomography (OCT). Additionally, cognitive impairment severity, brain atrophy, and cerebrospinal fluid (CSF) biomarkers were measured in AD patients. Results AD patients demonstrated a significant decrease in the average, superior, and inferior quadrant peripapillary retinal nerve fiber layer, macular retinal nerve fiber layer, ganglion cell layer (GCL), inner plexiform layer (IPL) thicknesses, as well as total macular volume (TMV) (all p < 0.05). Moreover, TMV was positively associated with Mini‐Mental State Examination and Montreal Cognitive Assessment scores, IPL thickness was correlated negatively with the medial temporal lobe atrophy score, and the GCL thickness was positively correlated with CSF Aβ 42 /Aβ 40 and negatively associated with p‐tau level. Based on the significantly decreased OCT variables between both groups, the XGBoost algorithm exhibited the best diagnostic performance for AD, whose four references, including accuracy, area under the curve, f1 score, and recall, ranged from 0.69 to 0.74. Moreover, the macular retinal thickness exhibited an absolute superiority for AD diagnosis compared with other enrolled variables in all ML models. Conclusion We identified the retinal alterations in AD patients and found that macular thickness and volume were associated with AD severity and biomarkers. Furthermore, we confirmed that OCT combined with ML could serve as a potential diagnostic tool for AD.
34
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
Yosef Koronyo, David Biggs, Ernesto Barrón et al. · JCI Insight · 2017 · 518 citations · Full text
Medicine, Neurology, Neuroscience +17
Visual assessment of posterior atrophy development of a MRI rating scale
Esther Koedam, Manja Lehmann, Wiesje M. van der Flier et al. · European Radiology · 2011 · 418 citations · Full text
Medicine, Neurology, Neuroscience +17
Melanopsin retinal ganglion cell loss in <scp>A</scp>lzheimer disease
Chiara La Morgia, Fred N. Ross‐Cisneros, Yosef Koronyo et al. · Annals of Neurology · 2015 · 397 citations · Full text
Medicine, Neurology, Neuroscience +17